Profiles of Obesity, Weight Gain, and Quality of Life in Idiopathic Intracranial Hypertension (Pseudotumor Cerebri)

American Journal of Ophthalmology

Volumn 143, Issue 4, 2007, Pages

  Daniels, Anthony B ^a   Liu, Grant T ^a   Volpe, Nicholas J ^a   Galetta, Steven L ^a   Moster, Mark L ^b   Newman, Nancy J ^c   Biousse, Valerie ^c   Lee, Andrew G ^d   Wall, Michael ^d   Kardon, Randy ^d   Acierno, Marie D ^e   Corbett, James J ^f   Maguire, Maureen G ^a   Balcer, Laura J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WILLS EYE HOSPITAL   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; BRAIN PSEUDOTUMOR; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE; NEUROOPHTHALMOLOGY; OBESITY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RISK FACTOR; SCORING SYSTEM; SHORT FORM 36; WEIGHT GAIN;

EID: 33947386717     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2006.12.040     Document Type: Article

References (26)

1. Smith J.L. Whence pseudotumor cerebri?. J Clin Neuroophthalmol 5 (1985) 55-56
2. Friedman D.I., and Jacobson D.M. Diagnostic criteria for idiopathic intracranial hypertension. Neurology 59 (2002) 1492-1495
3. Crock P.A., McKenzie J.D., Nicoll A.M., et al. Benign intracranial hypertension and recombinant growth hormone therapy in Australia and New Zealand. Acta Paediatr 87 (1998) 381-386
4. Foley J. Benign forms of intracranial hypertension: "toxic" and "otitic" hydrocephalus. Brain 78 (1955) 1-41
5. Bulens C., DeVries W.A.E.J., and Van Crevel H. Benign intracranial hypertension. J Neurol Sci 40 (1979) 147-157
6. Wysowski D.K., and Green L. Serious adverse events in Norplant users reported to the food and drug administration's MedWatch spontaneous reporting system. Obstet Gynecol 85 (1995) 538-542
7. Digre K.B., and Corbett J.J. Idiopathic intracranial hypertension (Pseudotumor cerebri): a reappraisal. Neurologist 7 (2001) 2-67
8. Chiu A.M., Chuenkongkaew W.L., Cornblath W.T., et al. Minocycline treatment and pseudotumor cerebri syndrome. Am J Ophthalmol 126 (1998) 116-121
9. Valentine G.H. Triamcinolone and intracranial hypertension: a side effect. Lancet 1 (1959) 892
10. Neville B.G., and Wilson J. Benign intracranial hypertension following corticosteroid withdrawal in childhood. Br Med J 3 (1970) 554-556
11. Giuseffi V., Wall M., Siegel P.Z., and Rojas P.B. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): a case-control study. Neurology 41 (1991) 239-244
12. Shin R.K., and Balcer L.J. New developments in idiopathic intracranial hypertension. Curr Neurol Neurosci Reports 1 (2001) 463-470
13. Durcan F.J., Corbett J.J., and Wall M. The incidence of pseudotumor cerebri: population studies in Iowa and Louisiana. Arch Neurol 45 (1988) 875-877
14. Carta A., Bertuzzi F., Cologno D., Giorgi C., Montanari E., and Tedesco S. Idiopathic intracranial hypertension (pseudotumor cerebri): descriptive epidemiology, clinical features, and visual outcome Parma, Italy, 1990 to 1999. Eur J Ophthalmol 14 (2004) 48-54
15. Wall M., and George A.E. Idiopathic intracranial hypertension: a prospective study of 50 patients. Brain 114 (1991) 155-180
16. Kleinschmidt J.J., Digre K.B., and Hanover R. Idiopathic intracranial hypertension. Relationship to depression, anxiety, and quality of life. Neurology 54 (2000) 319-324
17. Mangione CM. The National Eye Institute 25-Item Visual Function Questionnaire Scoring Algorithm, 2000. http://www.nei.nih.gov/resources/visionfunction/manual_cm2000.pdf.
18. Mangione C.M., Berry S., Spritzer K., et al. Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons. Arch Ophthalmol 116 (1998) 227-233
19. Mangione C.M., Lee P.P., Pitts J., et al. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). Arch Ophthalmol 116 (1998) 1496-1504
20. Mangione C.M., Lee P.P., Gutierrez P.R., et al. Development of the 25-Item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 119 (2001) 1050-1058
21. Ware Jr. J.E., and Kosinski M. SF-36 Physical and Mental Health Summary Scales: a manual for users of version 1. 2nd ed. (2001), QualityMetric Incorporated, Lincoln, RI
22. Ireland B., Corbett J.J., and Wallace R.B. The search for causes of idiopathic intracranial hypertension. A preliminary case-control study. Arch Neurol 47 (1990) 315-320
23. Subramanian P.S., Goldenberg-Cohen N., Shukla S., Cheskin L.J., and Miller N.R. Plasma ghrelin levels are normal in obese patients with idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol 138 (2004) 109-113
24. Johnson L.N., Krohel G.B., Madsen R.W., and March Jr. G.A. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology 105 (1998) 2313-2317
25. Friedman D.I. Medication-induced intracranial hypertension in dermatology. Am J Clin Dermatol 6 (2005) 29-37
26. Lee A.G. Pseudotumor cerebri after treatment with tetracycline and isotretinoin for acne. Cutis 55 (1995) 165-168